HomePBYI • NASDAQ
add
Puma Biotechnology Inc
Previous close
$4.96
Day range
$4.81 - $5.26
Year range
$2.13 - $7.73
Market cap
234.44M USD
Avg Volume
378.86K
P/E ratio
10.70
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 43.80M | -17.01% |
Operating expense | 35.40M | 0.59% |
Net income | -4.80M | -442.61% |
Net profit margin | -10.96 | -513.58% |
Earnings per share | -0.05 | -155.56% |
EBITDA | 579.75K | -92.00% |
Effective tax rate | -4.35% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | -3.49% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -4.80M | -442.61% |
Cash from operations | 11.30M | 327.54% |
Cash from investing | -19.10M | -9.46% |
Cash from financing | — | — |
Net change in cash | -7.80M | 47.32% |
Free cash flow | — | — |
About
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA. Wikipedia
Founded
2007
Headquarters
Website
Employees
185